ICAM1 and non-small cell lung carcinoma: Additionally, we obtained the NSCLC biomarkers from previous studies [3, 4] and analyzed their correlation with MYADM. It was found that MYADM had a high correlation with intercellular adhesion molecule-1 (ICAM1) and a weak correlation with RAS-related C3 botulinum toxin substrate 1 (RAC1), which demonstrated the potential of MYADM as a biomarker for NSCLC (Figures 5C,D).